Lanzoprax Kid 15mg Tablet contains Lansoprazole 15mg, a proton pump inhibitor (PPI) used primarily for the treatment of acid-related gastrointestinal conditions in pediatric patients. Lansoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This reduction in acid production helps in the management of conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome in children. Lanzoprax Kid is indicated for pediatric patients requiring acid suppression therapy, providing symptomatic relief and promoting mucosal healing. The 15mg dosage is specifically formulated to meet the therapeutic needs of children, ensuring efficacy while minimizing potential adverse effects. The tablet should be administered as directed by a healthcare professional, typically before meals to optimize acid suppression. Common side effects may include headache, abdominal pain, diarrhea, and nausea, though these are generally mild and transient. Caution is advised in patients with known hypersensitivity to lansoprazole or other PPIs. Regular monitoring may be necessary during prolonged therapy to assess treatment response and detect any potential complications. Lanzoprax Kid 15mg Tablet offers a reliable and effective option for pediatric acid-related disorders under medical supervision.